Ailei Qi

Title: Ailei Qi: Innovating Cancer Treatment through NK Cell Research

Introduction

Ailei Qi, an innovative inventor based in Beijing, China, has made significant strides in the field of medicine. With a focus on cancer treatment, he has developed methods that enhance therapeutic options for patients. His research and inventions contribute to the ever-evolving landscape of biomedical technology.

Latest Patents

Ailei Qi holds a patent titled "Preparation Method of NK Cells and Use Thereof in the Treatment of Cancer." This ground-breaking disclosure details a method for preparing Natural Killer (NK) cells and explores their application in treating cancer. The patent specifically outlines a pharmaceutical composition that combines NK cells with a monoclonal antibody targeting CD105. Notably, this composition shows promising potential for the treatment of colorectal cancer.

Career Highlights

Ailei Qi is a valued member of Sino United (Beijing) Biomedical Technology Co., Ltd., where he applies his expertise in biomedical research and development. His contributions to the company focus on advancing innovative solutions that address critical health challenges.

Collaborations

In his professional journey, Ailei Qi has collaborated with talented coworkers, including Aijie Qi and Shaobo Li. Together, they contribute to a collaborative environment that fosters research and innovation in biomedical technology.

Conclusion

Ailei Qi stands out as a key inventor in the realm of cancer treatment through his innovative use of NK cells. His patent and ongoing research contributed significant advancements for treating colorectal cancer, showcasing the impact of his work in the field of biomedical technology. As he continues to explore new frontiers in cancer treatment, Ailei's contributions are sure to leave a lasting legacy in medical science.